Strategies to Enhance Adoptive Transfer T Cell Clones
Strategies to Enhance Adoptive Transfer T Cell Clones
批准号:
7217915
负责人:
STANLEY R. RIDDELL
金额:
$38.36万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-02-28
关键词:
Adoptive ImmunotherapyAdoptive TransferAntigen TargetingAntigen-Presenting CellsAntigensCD8 AntigensCD8B1 geneCell SurvivalClinicalClinical ResearchClinical TrialsCommunicable DiseasesCulture TechniquesCytomegalovirusCytotoxic T-LymphocytesGoalsGrowthHumanIL2 geneImmuneImmune responseImmunityIn VitroInfectionInfection ControlInfusion proceduresInterleukin-15Interleukin-2InterleukinsLymphocyteLymphocyte CountMacaca mulattaMacaca nemestrinaMaintenanceMalignant NeoplasmsModelingMolecular ImmunologyNumbersRodent ModelSafetySpecificityT memory cellT-LymphocyteTherapeuticTranslatingTreatment Efficacybasecancer therapycytokinehuman diseaseimprovedin vivoinsightmigrationnonhuman primateresearch studyresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Studies in rodent models of cancer and infectious diseases have demonstrated that the adoptive transfer of T cells of defined antigen specificity and function can establish or augment an immune response in vivo and provide therapeutic benefit, and there is increasing evidence that adoptive immunotherapy with T cells has therapeutic activity in human malignancies and infection. However, in most clinical studies the infusion of large numbers of cultured T cells or T cell clones has failed to completely eradicate tumors or provide long-term control of infection. This is in part due to the inability with current approaches to establish an immune response of sufficient magnitude and persistence by adoptive transfer for sustained therapeutic efficacy. Studies of cytokines such as IL15 that regulate lymphocyte growth and survival, and of homeostatic mechanisms that operate to maintain lymphocyte numbers but permit expansion of antigen-specific T cells in response to in vivo stimulation have provided insights into strategies that might be employed to better establish T cell immunity by the adoptive transfer of T cell clones. The goals of this proposal are to develop strategies that improve the establishment of a persistent high-level antigen-specific T cell response in vivo by the adoptive transfer of CD8+ T cell clones, and can be applied to clinical trials of T cell therapy for cancer. The studies will be performed in non-human primates (Macacca nemestrina), and utilize CD8+ T cell clones specific for rhesus cytomegalovirus (rhCMV) as a model target antigen. Culture techniques that are routinely used to propagate human T cells for clinical adoptive T cell therapy will be employed to improve our ability to directly translate the results to studies of T cell therapy for human malignancy and infection. The specific aims are:
1). To determine the effect of the in vivo administration of interleukin (IL2) and interleukin 15 (IL15) on the persistence, function, and migration of adoptively transferred CD8+ antigen-specific T cell clones.
2). To determine the effects of lymphodepletion prior to T cell transfer on the persistence, function, and migration of adoptively transferred CD8+ antigen-specific T cell clones.
3). To determine whether the magnitude and persistence of a CD8+ cytotoxic T cell response established by adoptive transfer can be enhanced by antigen stimulation in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
-
批准号:10601293
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2019
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
-
批准号:10174871
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2019
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
-
批准号:10436174
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2019
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
-
批准号:10700908
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2019
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Targeting Alloreactivity for Leukemia Eradication
-
批准号:8277822
-
项目类别:
-
资助金额:$56.18万
-
财政年份:2011
-
负责人:STANLEY R. RIDDELL
-
依托单位:
STRATEGIES TO ENHANCE ADOPTIVE TRANSFER OF T CELL CLONES
-
批准号:8357607
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2011
-
负责人:STANLEY R. RIDDELL
-
依托单位:
STRATEGIES TO ENHANCE ADOPTIVE TRANSFER OF T CELL CLONES
-
批准号:8172773
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2010
-
负责人:STANLEY R. RIDDELL
-
依托单位:
EVALUATING THE ENGINEERING OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELL CLONES
-
批准号:8172786
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2010
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Targeted immunotherapy of breast cancer with central memory T cells
-
批准号:8181485
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2010
-
负责人:STANLEY R. RIDDELL
-
依托单位:
STRATEGIES TO ENHANCE ADOPTIVE TRANSFER OF T CELL CLONES
-
批准号:7958859
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2009
-
负责人:STANLEY R. RIDDELL
-
依托单位:
ANALYSIS OF A NOVEL SUBSET OF HUMAN CD8+ MEMORY CELLS WITH STEM CELL QUALITIES
-
批准号:7937922
-
项目类别:
-
资助金额:$47.97万
-
财政年份:2009
-
负责人:STANLEY R. RIDDELL
-
依托单位:
ANALYSIS OF A NOVEL SUBSET OF HUMAN CD8+ MEMORY CELLS WITH STEM CELL QUALITIES
-
批准号:7832350
-
项目类别:
-
资助金额:$47.97万
-
财政年份:2009
-
负责人:STANLEY R. RIDDELL
-
依托单位:
CONSENT TO PARTICIPATE AS A DONOR OF PERIPHERAL BLOOD MONONUCLEAR CELLS
-
批准号:7603442
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2007
-
负责人:STANLEY R. RIDDELL
-
依托单位:
PHASE I STUDY OF ADOPTIVE IMMUNOTHERAPY AFTER STEM CELL TRANSPLANT
-
批准号:7379322
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2006
-
负责人:STANLEY R. RIDDELL
-
依托单位:
CONSENT TO PARTICIPATE AS A DONOR OF PERIPHERAL BLOOD MONONUCLEAR CELLS
-
批准号:7379333
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2006
-
负责人:STANLEY R. RIDDELL
-
依托单位:
STRATEGIES TO ENHANCE ADOPTIVE TRANSFER OF T CELL CLONES
-
批准号:7349360
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2006
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
-
批准号:10365860
-
项目类别:
-
资助金额:$7.54万
-
财政年份:2005
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Strategies to improve the adoptive transfer of T cells
-
批准号:8403566
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2005
-
负责人:STANLEY R. RIDDELL
-
依托单位:
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
-
批准号:10601316
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2005
-
负责人:STANLEY R. RIDDELL
-
依托单位:
SAFETY AND EFFICACY OF CELLULAR ADOPTIVE IMMUNOTHERAPY
-
批准号:7198803
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2005
-
负责人:STANLEY R. RIDDELL
-
依托单位:
海外基金